Immunotherapy Combination May Benefit Patients with Transplanted Kidneys and Advanced Skin Cancers

La combinación de inmunoterapia puede beneficiar a pacientes con riñones trasplantados y cánceres de piel avanzados

Las personas que han recibido un trasplante de riñón tienen un alto riesgo de desarrollar cáncer de piel. Una nueva investigación dirigida por investigadores del Centro Oncológico Kimmel de Johns Hopkins está explorando la mejor combinación de tratamientos para combatir el cáncer de piel y al mismo tiempo preservar los órganos trasplantados.

LEER AQUÍ

VER TODAS LAS NOTICIAS

Mensajes recientes

New Technology: MRI-guided Focused Ultrasound for Prostate Cancer Advances in Breast Cancer Treatment: Insights from Medical Oncologist Jenni Sheng Early Immunotherapy Shows Promising Results in Advanced Basal Cell Carcinoma New NIH-Funded Johns Hopkins Medicine Study Finds High-Risk Individuals Who Have Mild Dilatation of the Pancreatic Duct Have Increased Risk for Pancreatic Cancer Lung Cancer Symptoms Doctors Say Women Should Never Ignore and the Screening Most Skip Targeted Radiation During Surgery Reduces Pancreatic Cancer Recurrence Colorectal Cancer Is Becoming More Common In Young People. Here Are The Signs. Johns Hopkins-Led Study Finds Drugs Approved for Treating Pain Also Reduce Bone Cancer Growth DNA Shed by Colon Cancers May Help Oncologists Personalize Postsurgical Treatment